精液质量较前下降,男性不育呈上升趋势,近十几年开始重视治疗男性不育症。经验表明,药物疗效不理想,手术受到适应症等因素限制,尚因特发性生精障碍占男性不育病因半数以上,应用药物和手术难以奏效。为满足不育症病人的生育厚望,近年男性不育症在治疗原则上完成了巨大变革——体外受精、显微授精和睾丸内精子回收等辅助生殖技术(Assisted reproductive technology,ART)异军突起,成为男性不育症治疗的主流。 Semen quality decreased compared with the previous, male infertility is on the rise, the past decade or so began to pay attention to the treatment of male infertility. Experience shows that the drug efficacy is not satisfactory, surgical indications and other factors, but also because of idiopathic sperm dysfunction accounted for more than half of the causes of male infertility, application of drugs and surgery is difficult to work. In order to meet the fertility expectations of infertile patients, male infertility has undergone tremendous changes in treatment in principle in recent years. Assisted reproductive technology (ART), such as in vitro fertilization, micro-insemination and intra-testicular sperm recovery, Mainstream male infertility treatment.